Kochujang, a Fermented Soybean-based Red Pepper Paste, Decreases Visceral Fat and Improves Blood Lipid Profiles in Overweight Adults
Launched by CHONBUK NATIONAL UNIVERSITY HOSPITAL · Feb 13, 2012
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study was to evaluate the efficacy of KCJ supplementation on anthropometric parameters, visceral fat/subcutaneous fat, and blood lipid profiles in overweight subjects.
Sixty overweight subjects with BMI \>25 kg/m2 and waist-hip-ratio (WHR) ≥ 0.90 for men and ≥ 0.85 for women were randomly assigned to either KCJ supplement (n=30, 32 g/day) or placebo (n=30, 32 g/day) group for 12 weeks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI \>25kg/m2 and 2)Waist-Hip Ratio (WHR): WHR\> 0.90(male), WHR\>0.85(female)
- Exclusion Criteria:
- • lipid metabolic disorders
- • \>10% changes in body weight in the past 3 months
- • Cardiovascular disease such as arrhythmia, heart failure, myocardial infarction, and wearing pacemaker
- • Allergy or hypersensitivity to any of the ingredients in the test products - History of reaction to any of the experimental products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
- • Participation in other clinical trials within the past 2 months
- • Abnormal hepatic liver function, renal disease such as acute
- • chronic renal failure, nephrotic syndrome
- • Use of anti-psychosis drug therapy within 2 months
- • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- • History of alcohol or substance abuse
- • Pregnancy or breastfeeding
About Chonbuk National University Hospital
Chonbuk National University Hospital (CBNUH) is a leading academic medical center located in Jeonju, South Korea, dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, CBNUH is committed to enhancing patient care by investigating novel therapeutic approaches and improving treatment outcomes. The hospital's multidisciplinary team of experienced researchers and healthcare professionals collaborates closely with international partners to ensure compliance with ethical standards and regulatory guidelines, fostering an environment of scientific excellence and patient safety. Through its robust research infrastructure, CBNUH aims to contribute significantly to the global body of medical knowledge and improve the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Soo-Wan Chae, Ph.D, MD
Study Chair
Chonbuk National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials